CNBX Pharmaceuticals Inc (OTCMKTS:CNBX) Stock Rallies After New Patent Granted in Australia

September 29, 2022

CNBX Pharmaceuticals Inc (OTCMKTS:CNBX) on September 28, 2022, announced receiving a Notice of Grant for Patent by IP Australia, part of the Australian Government. The notice pertains to the patent titled: System and Method for High Throughput Screening of Cancer Cells. Granted for two decades, the patent began in May 2016. Trading Data On Wednesday, CNBX stock moved up 7.14% to $3.0000 with 2.31K shares, compared to its average volume…